Your new experience awaits. Try the new design now and help us make it even better

CORRECTION article

Front. Pharmacol.

Sec. Pharmacology of Anti-Cancer Drugs

Volume 16 - 2025 | doi: 10.3389/fphar.2025.1705251

Correction: Targeting digestive system cancers with isoliquiritigenin: a comprehensive review of antitumor mechanisms

Provisionally accepted
Zhichun LiZhichun Li1Ruohan FengRuohan Feng2Jinze LiJinze Li3Jinglu BaiJinglu Bai3Nuo LiNuo Li2Zhenhua CuiZhenhua Cui3,4*Xiaobin ZhangXiaobin Zhang5*
  • 1Medical College, Shandong University of Traditional Chinese Medicine, Jinan, China
  • 2College of Pharmacy, Shandong University of Traditional Chinese Medicine, Jinan, China
  • 3College of Traditional Chinese Medicine, Shandong University of Traditional Chinese Medicine, Jinan, China
  • 4Department of Colorectal and Anal Surgery, The Second Hospital of Shandong University, Jinan, China
  • 5Department of Traditional Chinese Medicine External Treatment Center, Shandong University of Traditional Chinese Medicine Affiliated Hospital, Jinan, China

This article is a correction to:

  1. Targeting Digestive System Cancers with Isoliquiritigenin: A Comprehensive Review of Antitumor Mechanisms

    1. Read original article

The final, formatted version of the article will be published soon.

Select one of your emails

You have multiple emails registered with Frontiers:

Notify me on publication

Please enter your email address:

If you already have an account, please login

You don't have a Frontiers account ? You can register here

Correction: Targeting digestive system cancers with isoliquiritigenin: a comprehensive review of antitumor mechanisms Correction on: Li Z, Feng R, Li J, Bai J, Li N, Cui Z and Zhang X (2025) Targeting digestive system cancers with isoliquiritigenin: a comprehensive review of antitumor mechanisms. Front. Pharmacol. 16:1649472. doi: 10.3389/fphar.2025.1649472. Error in figure/table Wrong content The figures were in the wrong order in the PDF and HTML version of this paper. Figure 2 was published as Figure 3, Figure 3 was published as Figure 4, Figure 4 was published as Figure 6, Figure 5 was published as Figure 2, and Figure 6 was published as Figure 5. The order has now been corrected. The original version of this article has been updated. Reminder: Figures, tables, and images will be published under a Creative Commons CC-BY license and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, to follow any citation instructions requested by third-party rights holders, and cover any supplementary charges. End of template. If you would like to request a correction for a reason not seen here, please contact the journal's editorial office.

Keywords: Isoliquiritigenin, Digestive system cancers, licorice, Mechanism, natural compounds

Received: 14 Sep 2025; Accepted: 10 Oct 2025.

Copyright: © 2025 Li, Feng, Li, Bai, Li, Cui and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Zhenhua Cui, czh03146@sina.com
Xiaobin Zhang, zhangxiaobin199410@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Supplementary Material